Equity
€238,926 from €581,306 in 2017
Equity fell by 59% in 8 years.
B.D. FARMA
Lifetime
20 annual accounts with figures on one time axis, 29 filings since 1997peak €451,196 (2025)
€451,196▲ 8.8%
peak €191,690 (2025)
€191,690▲ 8.9%
peak €581,306 (2017)
€238,926▼ 3.4%
€323,558▲ 4.3%
peak 3.6 FTE (2013)
2.4 FTE▲ 4.3%
Board1 name since 2021
1 directorVEROFAR
Owners2 names in the annual accounts
100%Verofar
Documentsfilings and deeds
07-05-202685 days before the deadline
2025abbreviated format
Dividend €200,000Cash from €174,070 to €101,184
Key points
from the 2025 annual accountsFilings
29 annual accounts since 1997
The last five annual accounts were filed 34 to 112 days before the end of the period.
Position in the sector
€191,690
Higher net result than 87% of companies in retail trade. Sector median €27,487 · 12,827 companies.
Checked score
94
Excellent
Financially stronger than 57% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,276 companies (NACE 47, micro).
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025lowest value
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026highest value
07-2026: 0.1%● unchanged vs 06-2026highest value
08-2026: 0.1%● unchanged vs 07-2026highest value
09-2026: 0.1%● unchanged vs 08-2026highest value
10-2026: 0.1%● unchanged vs 09-2026highest value
11-2026: 0.1%● unchanged vs 10-2026highest value
Financial strengthStrong
Score breakdown
raises risk
Sector: Retail trade (NACE 47)
lowers risk
Founded in 1996
Liquidity: current ratio 1.72, cash €101,184
Equity €238,926 (42.5% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 57% of them on solvency, 41% on liquidity, 96% on profitability and 33% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 31,368 companies had the same profile as B.D. FARMA has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of B.D. FARMA itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,368 companies, not a prediction for B.D. FARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €22,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.72 (1.77 in 2024), above the usual 1.5. Short-term debt is 57.5% and cash 18% of total assets. However, 57.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-05-2026, 85 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
85 days early
2024
112 days early
2023
34 days early
2022
39 days early
2021
38 days early
2020
58 days early
2019
64 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 61 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 June (4 of the last 5 accounts filed within 46 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0458341331
Appointment: VEROFAR (sole director)
Permanent representative: Veronique Bertrand · Gazette deed
First establishment
B.D. FARMA NV, Zuidlaan 66, Zwalm
Incorporation
published on 23-07-1996 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| B.D. FARMA Zwalm | €562,484 | €451,196 | 42.5% | 2.4 |
| PHARMACIE DE LA COLLEGIALE Nivelles | €713,579 | €415,999 | 36.5% | 2.4 |
| APOTHEEK SPRIET Berlare | €772,384 | €471,593 | 32.3% | 2.7 |
| Apotheek Premereur Denderleeuw | €687,655 | €369,897 | 31.5% | 2.7 |
| APOTHEEK SOFIE DHONT Gavere | €692,188 | €360,858 | 32.4% | 1.8 |
| HERZELE FARMA Herzele | €785,100 | €496,528 | 30.4% | 3 |
| APOTHEEK MINNAERT Oosterzele | €635,368 | €386,273 | 20.3% | 2.7 |
These companies have the same main activity as B.D. FARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €635,000 and €785,000, founded between 1981 and 1999.
Official details
Source: KBO- Status
- Active since 25-06-1996Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Establishment unit
- 2.077.777.0189630 Zwalm, since 09-08-1996
- Financial year end
- 31 December
- Peppol
- Reachable since 31-10-2023
Annual accounts 2025
- ≈ €1.6mestimated
- €562,484▲ 0.9%
- Employeeson 31-12-2025
- 4=
- Filing
- Filed on 07-05-2026, 85 days before the end of the filing period
Insights on B.D. FARMA
B.D. FARMA files the abbreviated format. That format states no turnover. The gross margin rose from €226,920 in 2006 to €451,196 in 2025.
Verofar holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about B.D. FARMA
- What is the company number of B.D. FARMA?
- The company number of B.D. FARMA is 0458.341.331. The VAT number is the same number with BE in front: BE 0458.341.331.
- Where is B.D. FARMA based?
- The registered office is at Zuidlaan 66, 9630 Zwalm.Company details
- What does B.D. FARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of B.D. FARMA?
- B.D. FARMA is a public limited company (NV).
- When was B.D. FARMA founded?
- B.D. FARMA was founded on 25-06-1996.
- Is B.D. FARMA still active?
- Yes, B.D. FARMA is an active enterprise in the KBO register.
- How many employees does B.D. FARMA have?
- B.D. FARMA had an average of 2.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of B.D. FARMA?
- The turnover in financial year 2025 is ≈ €1.6m. This figure is estimated from the gross margin of €451,196 and 47 comparable companies (NACE 477). It probably lies between €1.2m and €2.5m.
- Is B.D. FARMA profitable?
- In financial year 2025, B.D. FARMA made a profit of €191,690.
- Where can I find the annual accounts of B.D. FARMA?
- B.D. FARMA filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of B.D. FARMA due?
- B.D. FARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.